Skip to main content

Cutaneous erythema predicted low-dose alemtuzumab response in leukemic cutaneous T-cell lymphoma

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Cutaneous erythema predicted low-dose alemtuzumab response in leukemic cutaneous T-cell lymphoma

User login

Username

Password

Reset your password

Type	Lead	score